Biocon shares rise 2% after USFDA concludes inspection with 5 observations

Biocon shares: The inspection, carried out from August 26 to September 3, 2025, spanned multiple operational areas such as drug substance manufacturing, analytical quality control labs, microbiology facilities, and warehouses.